Download PDF
Aktuelle Urol 2008; 39(4): 289-296
DOI: 10.1055/s-2008-1038199
Übersicht
© Georg Thieme Verlag Stuttgart · New York

Die Komplexität chronischer Beckenschmerzen am Beispiel der Interstitiellen Zystitis

Teil 2: TherapieThe Complexity of Chronic Pelvic Pain Exemplified by the Condition Currently Called Interstitial CystitisPart 2: TreatmentI.  Binder1 , G.  Rossbach1 , A. van  Ophoven2
  • 1Praxis für Hyperbarmedizin, Münster
  • 2Schwerpunkt für Neuro-Urologie, Urologische Universitätsklinik, Marienhospital Herne,Ruhr-Universität Bochum
Further Information

Publication History

Publication Date:
28 July 2008 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Die Interstitielle Zystitis ist ein chronisches Schmerzsyndrom und weniger eine reine Endorganerkrankung der Harnblase. Neue Definitions- und Nomenklaturvorschläge tragen dieser Kenntnis Rechnung. In Unkenntnis der Ätiologie und Pathogenese ist eine kausale Behandlung zurzeit nach wie vor nicht möglich. Es existiert weder ein evidenzbasierter Therapiealgorithmus noch eine sog. Standardtherapie. Die bislang unternommenen Therapieansätze sind sehr vielfältig. Die therapeutischen Ansätze können in orale, intravesikale, operative und physikalische Verfahren unterteilt werden. Auch gibt es sinnvolle ergänzende Therapieverfahren jenseits der klassischen Schulmedizin. Grundlage jeder Schmerztherapie stellt das WHO-Stufenschema dar. Unter den oralen Therapieverfahren werden z.Zt. folgende Medikamente mit unterschiedlichen Evidenzleveln empfohlen: Amitriptylin, Hydroxyzin, Pentosanpolysulfat. Viele weitere orale Medikamente werden eingesetzt, wobei der Nachweis ihrer Wirksamkeit z. T. lückenhaft ist, darunter Antikonvulsiva, L-Arginin und verschiedene Immunmodulatoren und -suppressiva. Bei den intravesikalen Therapieverfahren finden Botulinumtoxin A, Dimethylsulfoxid, Heparin und Glykosaminoglykan-Ersatzstoffe Anwendung. Unter den physikalischen Therapieverfahren gilt neben der Blasendistension die hyperbare Sauerstofftherapie als wirksame Therapieform. Bei Versagen der konventionellen Therapieverfahren stellen die operative (Teil-)Entfernung der Harnblase oder Harnumleitungsoperationen die therapeutische Ultima Ratio dar. Kontrollierte Studien zu alternativen Heilverfahren existieren kaum; recht gute Resultate bei chronischen Beckenschmerzsyndromen konnten aber mit Akupunktur als additives Therapieverfahren erreicht werden.

Abstract

The so-called interstitial cystitis is a chronic pain syndrome rather than a purely end organ disease of the urinary bladder. New suggestions for definitions and nomenclature take this into consideration. Since aetiology and pathogenesis are still unknown a treatment of the cause is still not possible. There are neither evidence-based treatment algorithms nor a so-called standard therapy. Numerous therapeutic approaches have been tried up to now. These attempts can be divided into oral, intravesical, surgical and physical procedures. There are also meaningful supplementary therapy procedures beyond the boundaries of classical school medicine. The WHO staging scheme provides the basis for every pain therapy. For the oral therapeutic procedures in current use the following medications with differing levels of evidence have been recommended: amitriptylin, hydroxyzin, pentosan polysulfate. Many other orally administered drugs have also been used although in many cases evidence of efficacy is lacking, these included anticonvulsants, L-arginine and various immunomodulators and immunosuppressants. Among the intravesical therapeutic procedures botulinum toxin A, dimethyl sulfoxide, heparin and glycosaminoglycan substitutes have been used. For the physical procedures, besides bladder distension, hyperbaric oxygen therapy shows efficacy. When the conventional therapeutic methods fail, surgical (partial) removal of the urinary bladder or urinary diversion procedures represent the therapeutic ultimo ratio. There are hardly any controlled studies on alternative curative procedures although rather good results have been obtained in chronic pelvic pain syndrome with acupuncture as an additional therapeutic modality.

Schlüsselwörter

Definition - Nomenklatur - Pathogenese - Diagnostik - klinische Studien

Key words

definition - nomenclature - aetiology - diagnosis - clinical trials

Literatur

  • 1 Bade J J, Laseur M, Nieuwenburg A, Weele L T van der, Mensink H J. A placebo-controlled study of intravesical pentosanpolysulphate for the treatment of interstitial cystitis.  British Journal of Urology. 1997;  79 (2) 68-171
    Google Scholar
  • 2 Badenoch A W. Chronic interstitial cystitis.  British Journal of Urology. 1971;  43 (6) 718-721
    Google Scholar
  • 3 Baskin L S, Tanagho E A. Pelvic pain without pelvic organs.  J Urol. 1992;  147 (3) 683-686
    Google Scholar
  • 4 Bouchelouche K, Nordling J, Hald T, Bouchelouche P. The cysteinyl leukotriene d4 receptor antagonist montelukast for the treatment of interstitial cystitis.  J Urol. 2001;  166 (5) 1734-1737
    Google Scholar
  • 5 Capelli-Schellpfeffer M, Gerber G S. The use of hyperbaric oxygen in urology.  J Urol. 1999;  162 (3 Pt 1) 647-654
    Google Scholar
  • 6 Cartledge J J, Davies A M, Eardley I. A randomized double-blind placebo-controlled crossover trial of the efficacy of L-arginine in the treatment of interstitial cystitis.  BJU Int. 2000;  85 (4) 421-426
    Google Scholar
  • 7 Daha L K, Riedl C R, Hohlbrugger G, Knoll M, Engelhardt P F, Pfluger H. Comparative assessment of maximal bladder capacity, 0.9 % NaCl versus 0.2 M Kcl, for the diagnosis of interstitial cystitis: a prospective controlled study.  J Urol. 2003;  170 (3) 807-809
    Google Scholar
  • 8 Davis E L, El Khoudary S R, Talbott E O, Davis J, Regan L J. Safety and efficacy of the use of intravesical and oral pentosan polysulfate sodium for interstitial cystitis: a randomized double-blind clinical trial.  J Urol. 2008;  179 (1) 177-185
    Google Scholar
  • 9 Emmons S L, Otto L. Acupuncture for overactive bladder: a randomized controlled trial.  Obstet Gynecol. 2005;  106 (1) 138-143
    Google Scholar
  • 10 Erickson D R. Interstitial cystitis: update on etiologies and therapeutic options.  J Womens Health Gend Based Med. 1999;  8 (6) 745-758
    Google Scholar
  • 11 Erickson D R, Belchis D A, Dabbs D J. Inflammatory cell types and clinical features of interstitial cystitis.  J Urol. 1997;  158 (3 Pt 1) 790-793
    Google Scholar
  • 12 Forsell T, Ruutu M, Isoniemi H, Ahonen J, Alfthan O. Cyclosporine in severe interstitial cystitis.  Journal of Urology. 1996;  155 (5) 1591-1593
    Google Scholar
  • 13 Franksson C. Interstitial cystitis: a clinical study of fifty-nine cases.  Acta Chirurgica Scandinavica. 1957;  113 51-62
    Google Scholar
  • 14 Giannantoni A, Porena M, Costantini E, Zucchi A, Mearini L, Mearini E. Botulinum A Toxin Intravesical Injection in Patients With Painful Bladder Syndrome: 1-Year Followup.  J Urol. 2008;  179 (3) 1031-1034
    Google Scholar
  • 15 Glemain P, Riviere C, Lenormand L, Karam G, Bouchot O, Buzelin J M. Prolonged hydrodistention of the bladder for symptomatic treatment of interstitial cystitis: efficacy at 6 months and 1 year.  Eur Urol. 2002;  41 (1) 79-84
    Google Scholar
  • 16 Grossklaus D J, Franke J J. Vesical necrosis after hydrodistension of the urinary bladder in a patient with interstitial cystitis.  BJU Int. 2000;  86 (1) 140-141
    Google Scholar
  • 17 Hanno P, Keay S, Moldwin R, Ophoven A van. International Consultation on IC-Rome, September 2004/Forging an International Consensus: progress in painful bladder syndrome/interstitial cystitis. Report and abstracts.  Int Urogynecol J Pelvic Floor Dysfunct. 2005;  16 Suppl 1 S2-S34
    Google Scholar
  • 18 Hanno P M, Buehler J, Wein A J. Use of amitriptyline in the treatment of interstitial cystitis.  Journal of Urology. 1989;  141 (4) 846-848
    Google Scholar
  • 19 Herwig R, Oberpenning F. [Alternative and complementary therapeutic measures in interstitial cystitis].  Urologe A. 2000;  39 (6) 551-553
    Google Scholar
  • 20 Hwang P, Auclair B, Beechinor D, Diment M, Einarson T R. Efficacy of pentosan polysulfate in the treatment of interstitial cystitis: a meta-analysis.  Urology. 1997;  50 (1) 39-43
    Google Scholar
  • 21 Kallestrup E B, Jorgensen S S, Nordling J, Hald T. Treatment of interstitial cystitis with Cystistat: a hyaluronic acid product.  Scand J Urol Nephrol. 2005;  39 (2) 143-147
    Google Scholar
  • 22 Kirkemo A K, Miles B J, Peters J M. Use of amitriptyline in interstitial cystitis.  Journal of Urology. 1990;  143 279 (A)
    Google Scholar
  • 23 Korting G E, Smith S D, Wheeler M A, Weiss R M, Foster Jr H E. A randomized double-blind trial of oral L-arginine for treatment of interstitial cystitis.  Journal of Urology. 1999;  161 (2) 558-565
    Google Scholar
  • 24 Kuo H C. Urodynamic results of intravesical heparin therapy for women with frequency urgency syndrome and interstitial cystitis.  J Formos Med Assoc. 2001;  100 (5) 309-314
    Google Scholar
  • 25 Kuo H C. Preliminary results of suburothelial injection of botulinum a toxin in the treatment of chronic interstitial cystitis.  Urol Int. 2005;  75 (2) 170-174
    Google Scholar
  • 26 Larsen S, Thompson S A, Hald T. et al . Mast cells in interstitial cystitis.  British Journal of Urology. 1982;  54 (3) 283-286
    Google Scholar
  • 27 Lasanen L T, Tammela T L, Kallioinen M, Waris T. Effect of acute distension on cholinergic innervation of the rat urinary bladder.  Urological Research. 1992;  20 (1) 59-62
    Google Scholar
  • 28 Lee S W, Liong M L, Yuen K H. et al . Acupuncture versus sham acupuncture for chronic prostatitis/chronic pelvic pain.  Am J Med. 2008;  121 (1) 79.e1 – 7
    Google Scholar
  • 29 Lundberg J O, Ehren I, Jansson O. et al . Elevated nitric oxide in the urinary bladder in infectious and noninfectious cystitis.  Urology. 1996;  48 (5) 700-702
    Google Scholar
  • 30 Mayer R, Propert K J, Peters K M. et al . A randomized controlled trial of intravesical bacillus calmette-guerin for treatment refractory interstitial cystitis.  J Urol. 2005;  173 (4) 1186-1191
    Google Scholar
  • 31 Mayer R D, Howard F M. Sacral nerve stimulation: neuromodulation for voiding dysfunction and pain.  Neurotherapeutics. 2008;  5 (1) 107-113
    Google Scholar
  • 32 Melchior D, Packer C S, Johnson T C, Kaefer M. Dimethyl Sulfoxide: Does It Change the Functional Properties of the Bladder Wall?.  J Urol. 2003;  170 (1) 253-258
    Google Scholar
  • 33 Morales A, Emerson L, Nickel J C, Lundie M. Intravesical hyaluronic acid in the treatment of refractory interstitial cystitis.  Journal of Urology. 1996;  156 (1) 45-48
    Google Scholar
  • 34 Moran P A, Dwyer P L, Carey M P, Maher C F, Radford N J. Oral methotrexate in the management of refractory interstitial cystitis.  Aust N Z J Obstet Gynaecol. 1999;  39 (4) 468-471
    Google Scholar
  • 35 Nickel J C, Barkin J, Forrest J. et al . Randomized, double-blind, dose-ranging study of pentosan polysulfate sodium for interstitial cystitis.  Urology. 2005;  65 (4) 654-658
    Google Scholar
  • 36 O'Reilly B A, Dwyer P L, Hawthorne G. et al . Transdermal posterior tibial nerve laser therapy is not effective in women with interstitial cystitis.  J Urol. 2004;  172 ( 5 Pt 1) 1880-1883
    Google Scholar
  • 37 Oravisto K J, Alfthan O S. Treatment of interstitial cystitis with immunosuppression and chloroquine derivatives.  European Urology. 1976;  2 (2) 82-84
    Google Scholar
  • 38 Parsons C L. Current strategies for managing interstitial cystitis.  Expert Opin Pharmacother. 2004;  5 (2) 287-293
    Google Scholar
  • 39 Parsons C L. Successful downregulation of bladder sensory nerves with combination of heparin and alkalinized lidocaine in patients with interstitial cystitis.  Urology. 2005;  65 (1) 45-48
    Google Scholar
  • 40 Parsons C L, Housley T, Schmidt J D, Lebow D. Treatment of interstitial cystitis with intravesical heparin.  British Journal of Urology. 1994;  73 (5) 504-507
    Google Scholar
  • 41 Peeker R, Aldenborg F, Fall M. Complete transurethral resection of ulcers in classic interstitial cystitis.  Int Urogynecol J Pelvic Floor Dysfunct. 2000;  11 (5) 290-295
    Google Scholar
  • 42 Peeker R, Haghsheno M A, Holmang S, Fall M. Intravesical bacillus Calmette-Guerin and dimethyl sulfoxide for treatment of classic and nonulcer interstitial cystitis: a prospective, randomized double-blind study [In Process Citation].  J Urol. 2000;  164 (6) 1912-1916
    Google Scholar
  • 43 Peng C H, Kuo H C. Multiple intravesical instillations of low-dose resiniferatoxin in the treatment of refractory interstitial cystitis.  Urol Int. 2007;  78 (1) 78-81
    Google Scholar
  • 44 Perez-Marrero R, Emerson L E, Feltis J T. A controlled study of dimethyl sulfoxide in interstitial cystitis [see comments].  Journal of Urology. 1988;  140 (1) 36-39
    Google Scholar
  • 45 Perez-Marrero R, Emerson L E, Maharajh D O, Juma S. Prolongation of response to DMSO by heparin maintenance.  Urology. 1993;  41 (1 Suppl) 64-66
    Google Scholar
  • 46 Peters K, Diokno A, Steinert B. et al . The efficacy of intravesical Tice strain bacillus Calmette-Guerin in the treatment of interstitial cystitis: a double-blind, prospective, placebo controlled trial.  Journal of Urology. 1997;  157 (6) 2090-2094
    Google Scholar
  • 47 Peters K M, Diokno A C, Steinert B W, Gonzalez J A. The efficacy of intravesical bacillus Calmette-Guerin in the treatment of interstitial cystitis: long-term followup.  J Urol. 1998;  159 (5) 1483-1486; discussion 1486 – 1487
    Google Scholar
  • 48 Peters K M, Feber K M, Bennett R C. A prospective, single-blind, randomized crossover trial of sacral vs pudendal nerve stimulation for interstitial cystitis.  BJU Int. 2007;  100 (4) 835-839
    Google Scholar
  • 49 Pontari M A, Hanno P M, Ruggieri M R. Comparison of bladder blood flow in patients with and without interstitial cystitis.  Journal of Urology. 1999;  162 (2) 330-334
    Google Scholar
  • 50 Propert K J, Mayer R, Nickel J C. et al . Followup of Patients With Interstitial Cystitis Responsive to Treatment With Intravesical Bacillus Calmette-Guerin or Placebo.  J Urol. 2008;  179 (2) 552-555
    Google Scholar
  • 51 Rosamilia A, Cann L, Dwyer P, Scurry J, Rogers P. Bladder microvasculature in women with interstitial cystitis [see comments].  Journal of Urology. 1999;  161 (6) 1865-1870
    Google Scholar
  • 52 Rosamilia A, Dwyer P L, Gibson J. Electromotive drug administration of lidocaine and dexamethasone followed by cystodistension in women with interstitial cystitis.  International Urogynecology Journal & Pelvic Floor Dysfunction. 1997;  8 (3) 142-145
    Google Scholar
  • 53 Rossberger J, Fall M, Peeker R. Critical appraisal of dimethyl sulfoxide treatment for interstitial cystitis discomfort, side-effects and treatment outcome.  Scand J Urol Nephrol. 2005;  39 (1) 73-77
    Google Scholar
  • 54 Rovner E, Propert K J, Brensinger C. et al . Treatments used in women with interstitial cystitis: the interstitial cystitis data base (ICDB) study experience. The Interstitial Cystitis Data Base Study Group.  Urology. 2000;  56 (6) 940-945
    Google Scholar
  • 55 Sairanen J, Forsell T, Ruutu M. Long-term outcome of patients with interstitial cystitis treated with low dose cyclosporine A.  J Urol. 2004;  171 (6, Part 1 Of 2) 2138-2141
    Google Scholar
  • 56 Sairanen J, Tammela T L, Leppilahti M. et al . Cyclosporine A and pentosan polysulfate sodium for the treatment of interstitial cystitis: a randomized comparative study.  J Urol. 2005;  174 (6) 2235-2238
    Google Scholar
  • 57 Sant G R, Propert K J, Hanno P M. et al . A pilot clinical trial of oral pentosan polysulfate and oral hydroxyzine in patients with interstitial cystitis.  J Urol. 2003;  170 (3) 810-815
    Google Scholar
  • 58 Schulman S P, Becker L C, Kass D A. et al . L-arginine therapy in acute myocardial infarction: the Vascular Interaction With Age in Myocardial Infarction (VINTAGE MI) randomized clinical trial.  JAMA. 2006;  295 (1) 58-64
    Google Scholar
  • 59 Shanberg A M, Baghdassarian R, Tansey L A. Treatment of interstitial cystitis with the neodymium-YAG laser.  Journal of Urology. 1985;  134 (5) 885-888
    Google Scholar
  • 60 Shorter B, Lesser M, Moldwin R M, Kushner L. Effect of Comestibles on Symptoms of Interstitial Cystitis.  J Urol. 2007;  178 (1) 145-152
    Google Scholar
  • 61 Smith C P, Radziszewski P, Borkowski A, Somogyi G T, Boone T B, Chancellor M B. Botulinum toxin a has antinociceptive effects in treating interstitial cystitis.  Urology. 2004;  64 (5) 871-875 discussion 875
    Google Scholar
  • 62 Theoharides T C, Cochrane D E. Critical role of mast cells in inflammatory diseases and the effect of acute stress.  J Neuroimmunol. 2004;  146 (1 – 2) 1-12
    Google Scholar
  • 63 Theoharides T C, Kempuraj D, Sant G R. Mast cell involvement in interstitial cystitis: a review of human and experimental evidence.  Urology. 2001;  57 (6 Suppl 1) 47-55
    Google Scholar
  • 64 Theoharides T C, Sant G R. Hydroxyzine therapy for interstitial cystitis.  Urology. 1997;  49 (5A Suppl) 108-110
    Google Scholar
  • 65 Thilagarajah R, Witherow R O, Walker M M. Oral cimetidine gives effective symptom relief in painful bladder disease: a prospective, randomized, double-blind placebo-controlled trial.  BJU Int. 2001;  87 (3) 207-212
    Google Scholar
  • 66 Ueda T, Tamaki M, Ogawa O, Yamauchi T, Yoshimura N. Improvement of interstitial cystitis symptoms and problems that developed during treatment with oral IPD-1151T.  J Urol. 2000;  164 (6) 1917-1920
    Google Scholar
  • 67 Ophoven A van. Re: Urinary conduit formation using a retubularized bowel from continent urinary diversion or intestinal augmentations: II. Does it have a role in patients with interstitial cystitis?.  J Urol. 2005;  173 (4) 1435
    Google Scholar
  • 68 Ophoven A van, Heinecke A, Hertle L. Safety and efficacy of concurrent application of oral pentosan polysulfate and subcutaneous low-dose heparin for patients with interstitial cystitis.  Urology. 2005;  66 (4) 707-711
    Google Scholar
  • 69 Ophoven A, Hertle L. Long-term results of amitriptyline therapy for interstitial cystitis.  J Urol. 2005;  174 312
    Google Scholar
  • 70 Ophoven A van, Hertle L. The dual serotonin and noradrenaline reuptake inhibitor duloxetine for the treatment of interstitial cystitis: results of an observational study.  J Urol. 2007;  177 (2) 552-555
    Google Scholar
  • 71 Ophoven A van, Oberpenning F, Hertle L. Long-term results of trigone-preserving orthotopic substitution enterocystoplasty for interstitial cystitis.  J Urol. 2002;  167 (2 Pt 1) 603-607
    Google Scholar
  • 72 Ophoven A van, Pokupic S, Heinecke A, Hertle L. A prospective, randomized, placebo controlled, double-blind study of amitriptyline for the treatment of interstitial cystitis.  J Urol. 2004;  172 (2) 533-536
    Google Scholar
  • 73 Ophoven A van, Rossbach G, Oberpenning F, Hertle L. Hyperbaric oxygen for the treatment of interstitial cystitis: long-term results of a prospective pilot study.  Eur Urol. 2004;  46 (1) 108-113
    Google Scholar
  • 74 Ophoven A van, Rossbach G, Pajonk F, Hertle L. Safety and efficacy of hyperbaric oxygen therapy for the treatment of interstitial cystitis: a randomized, sham controlled, double-blind trial.  J Urol. 2006;  176 (4) 1442-1446
    Google Scholar
  • 75 Whitmore K E. Complementary and alternative therapies as treatment approaches for interstitial cystitis.  Rev Urol. 2002;  4 Suppl 1 S28-35
    Google Scholar
  • 76 Yamada T, Murayama T, Andoh M. Adjuvant hydrodistension under epidural anesthesia for interstitial cystitis.  Int J Urol. 2003;  10 (9) 463-468
    Google Scholar
  • 77 Zhang Q, Chang Q, Cox R A, Gong X, Gould L J. Hyperbaric Oxygen Attenuates Apoptosis and Decreases Inflammation in an Ischemic Wound Model.  J Invest Dermatol. 2008 Mar 13;  ISSN 1523 – 1747 (electronic), in press
    Google Scholar
  • 78 Zhao J, Nordling J. Posterior tibial nerve stimulation in patients with intractable interstitial cystitis.  BJU Int. 2004;  94 (1) 101-104
    Google Scholar

Priv.-Doz. Dr. med. Arndt van Ophoven

Schwerpunkt für Neuro-Urologie, Urologische Universitätsklinik, Marienhospital, Ruhr-Universität Bochum

Widumerstr. 8

44627 Herne

Email: arndt.vanophoven@marienhospital-herne.de

    Editorial Comment zur Übersicht.
>